Introduction
This paper examines the application of the health-related Millennium Development Goals The overall aim of the MDGs is to reverse the spread of poverty and disease by 2015.
The eight goals are backed by a plan of action that sets out 18 quantifiable targets, each using specified indicators. Three goals and four targets are directly related to health.
Goal 4 is to reduce child mortality. The related target is to reduce the under-five mortality rate by two-thirds, between 1990 and 2015. Goal 5 is the improvement of maternal health, with the target of reducing the maternal mortality rate by three-quarters, between 1990 and 2015. Goal 6 calls for combating HIV/AIDS, malaria and other diseases. The related targets are to have halted by 2015 and begun to reverse the spread of HIV/AIDS, and to have halted by 2015 and begun to reverse the incidence of malaria and other major diseases (The World Bank Group 2003; UNDP 2003) .
Our analysis looks at the impact of four scenarios on life expectancy at birth: 1) achieving the targets set out in the MDGs for infant, child (1-4 years) and maternal mortality;
2) reducing infant, child and maternal mortality to European Union levels (as an indicator of the situation in a part of Europe to which countries in this region often aspire);
3) reducing infant, child and maternal mortality to the lowest current levels in the sub-region (as an indication of what is arguably achievable now); 4) reducing deaths from cardiovascular disease and external causes of death to European Union levels (as an example of a strategy that would move on from the current MDGs to focus on major causes of adult mortality).
The MDGs focus the attention of the international community on important indicators of development (UNDP 2003; Haines and Cassels 2004) . However, they are more relevant for some countries or regions than for others. We argue that the choice of MDGs and their corresponding targets focus on sub-Saharan Africa in two important ways. The major reason is that rates of under-five mortality, maternal mortality, and HIV/AIDS infection rates are the highest in the world and progress in reducing these rates have so far been very limited (UNDP 2003) . The second reason is that, unlike other health problems, these are more easily visible. The 2000 World Health Report, for example, used childhood mortality to assess equity of outcome in its measure of health care system performance, because these data were much more widely available than data on adult mortality (WHO 2000) . Data on infant, maternal, and to a lesser extent childhood mortality are collected in many developing countries either by means of routine collection systems or intermittent surveys, in particular the series of Demographic and Health Surveys. With the exception of some innovative sentinel programmes (Garenne, Kahn et al. 2000) and the recently established Indepth Network (www.indepthnetwork.org), much less systematic recording of adult mortality exists. As a consequence, estimated life expectancy at birth is derived by means of modeling techniques, in which available information is applied to standard life tables (Coale and Demeny 1966) .
The choice of more readily available measures of childhood and maternal mortality as indicators of development is influenced by the view that they will broadly reflect the overall health of a population. Yet in those settings in the developing world where adult mortality has been studied it has also been found to be very high, especially from cardiovascular diseases and injuries (Garenne, Kahn et al. 2000; Walker, McLarty et al. 2000; Moshiro, Mswia et al. 2001) . However this burden of avoidable disease remains largely invisible and has so far not been adequately used to monitor health trends.
In the former Soviet bloc the situation is different in both aspects. First of all, premature mortality is driven by deaths in adulthood. Childhood and maternal mortality, while still much higher than in advanced industrialized countries, have been reduced in the decades following the Second World War, although maternal mortality has increased again in many places after 1990. Furthermore, comprehensive systems to monitor vital statistics were put in place, which, although flawed, make it possible to measure and track adult mortality in a way that is not easily possible in sub-Saharan Africa.
Concerns have therefore been raised as to whether the health-related MDGs are appropriate for the transition countries of Eastern Europe and Central Asia, as they focus attention on childhood and maternal mortality and exclude general adult mortality. Our previous analysis of life expectancy in Russia argued that the health-related International Development Targets had limited relevance for Russia. The analysis covered the population of the Russian Federation in 1995-1999 and used life expectancy as the measure of population health. A reduction of infant and child mortality rates by twothirds and maternal mortality rates by three-quarters was found to result in an overall increase of only 0.96 years in life expectancy at birth. In contrast, a 20% reduction in adult mortality would have resulted in an increase of 1.86 years in male life expectancy.
A further analysis looked at the effect of narrowing the east-west gap in Europe; a reduction of adult mortality to British levels for cardiovascular diseases and external causes of death resulted in an increase in life expectancy at birth of 5.97 years for both sexes (Lock, Andreev et al. 2002) .
Apart from this analysis on Russia, surprisingly little has been published on the appropriateness of global development targets for health in Eastern Europe and Central Asia. Our search using PubMed/Medline in June 2003 could not identify any other publication on the subject. Nevertheless, the situation is likely to be similar in many other Eastern European transition countries. In these countries, under-five and maternal mortality are much lower than in countries at similar levels of economic development in other parts of the world. Adult mortality, on the other hand, contributes most to the burden of disease and premature mortality. Deaths due to cardiovascular diseases exceed Before proceeding with the scenarios considered in this article, the following Section 2 discusses the quality of the data used. Section 3 then describes the methods applied in the analytical part of the study. Section 4 provides the results of the analysis, which are discussed in more detail in Section 5. Finally, Section 6 draws conclusions that are relevant to the region and the focus of development assistance.
Data Quality
Although the government of the Soviet Union and its eastern European satellites created extensive systems of vital registration, it cannot be assumed that health data for Eastern Europe and Central Asia are now of uniformly high quality. A major problem in some countries is the absence of accurate population data. Since 1989, wars and conflicts, combined with economic and social turmoil and the opening of borders, have triggered large-scale population movements that have often remained poorly quantified.
Another problem is that health information systems deteriorated or, in some cases, collapsed. A recalculation of life expectancy in Georgia concluded that official data may overestimate life expectancy at birth by as much as 8 years (Badurashvili, McKee et al. 2001 ).
Shifting definitions is a further problem. A study in Croatia showed that official mortality data were unreliable for the 1990s, with one of the main problems that the population denominator used before 1996 included not only people living in Croatia, but also Croatian citizens living permanently abroad (Bozicevic, Oreskovic et al. 2001 ).
Particularly serious concerns have been raised about the quality of data on infant and child mortality, in particular for Central Asia and the Caucasus. In view of these problems with the quality of data, UN organizations such as UNICEF and the World Bank have produced alternative data sets on infant and child mortality, using models that include data from surveys and other sources. As a consequence, the health-related Millennium Development targets that were established on the basis of estimates of 1990 levels, as well as measurement of progress towards these targets by World Bank and UNDP are based on World Bank estimates of infant and child mortality rather than on national registration data.
Although estimates based on survey data are likely to reflect the real infant mortality rates in Central Asia and the Caucasus better than national registration data, they too have limitations. Surveys are associated with a number of errors that limit their capacity to gauge current levels of infant and child mortality and even more so when assessing infant and child mortality up to ten years previously. Where indirect estimates of infant mortality are used, as in the Multiple Indicator Cluster Surveys, extra potential sources of error are introduced (Aleshina and Redmond 2003) .
The methods used to estimate childhood mortality from these data have been neither consistent nor transparent. In effect, different UN organizations are using different datasets and it is often unclear, or at least very difficult to discover, what data were used and how the resulting figures were generated. Interpretation and subjective judgments play a considerable part in production of the estimates. The uncertainties associated with surveys and survey-based estimates mean that surveys can only ever be partial solutions to the problem of incomplete vital registration.
A more fundamental drawback when using World Bank data is that some indicators, such as maternal mortality rates in 1990, are missing from the published tables and others, such as infant mortality, are incomplete. If the intention is to track changes, WHO, recording national registration data supplied by the countries, is the only complete source of the data required. However, since the quality of data in many countries is either poor or doubtful, the data have limited usefulness for serious policy decisions.
As long as national registration is incomplete, the exact levels of childhood mortality in Central Asia and the Caucasus will remain unknown. In this context, the analysis of the impact of the health-related Millennium Development Goals on these countries in the current study was confronted with the choice of whether to use national registration data or survey-based estimates. It was decided to use both datasets in two parallel calculations. National registration data were used for all scenarios considered in this study. Where, in addition, survey-based estimates by the World Bank were available for the countries of Central Asia and the Caucasus, as was the case for infant and child mortality, an additional analysis based on these estimates was undertaken. Although neither of these two approaches may be entirely accurate, the aim was to make the best use of currently available data.
Methods
This analysis is primarily based on population and mortality data by age, sex and cause of Using the official data reported by the countries to WHO, life expectancies were tabulated. The effects on life expectancy at birth were then calculated for the following four scenarios: 1) achieving MDG targets for infant, child and maternal mortality;
2) reducing infant, child and maternal mortality to EU-15 levels;
3) reducing infant, child and maternal mortality to the lowest sub-regional levels; 4) keeping infant, child and maternal mortality constant and reducing deaths from cardiovascular disease and external causes of death to EU-15 levels.
Where regional and sub-regional averages are shown they have been populationweighted. In countries that have already achieved or over-achieved the target levels of the scenarios, the lower of the two figures was taken as the target, as it was assumed, for present purposes, that none of these countries (all among the most advanced in the region) would relinquish their achievements. As maternal mortality ratios are expressed in terms of numbers of live births it was necessary to adapt them for use in the life tables.
This was done by setting the target as the current death rate from maternal causes in the age group 15-49 times the ratio of the target maternal mortality rate per 100,000 live births to the current rate. In effect this meant assuming that the current live birth rate would be unchanged.
As has been noted previously, achievement of Millennium Development Goal 6 (combating HIV/AIDS, malaria, and tuberculosis) has not been included in the analysis, since the impact of these diseases on life expectancy at birth is still relatively small. However, it is important to recognize that this will change dramatically in the near future. Scenario 4 kept infant, child and maternal mortality rates constant, and reduced the deaths from cardiovascular disease and external causes of deaths to the current EU-15 average.
Because of the known problems with data from Central Asia and the Caucasus, the analyses for these countries were undertaken separately in the first three scenarios for infant and child mortality, using both national vital registration data as reported to WHO and World Bank estimates of infant and child mortality. In the latter case, World Bank estimates of infant and child mortality rates were substituted in the life tables. For Scenario 1, the targets for Goal 4 were established on the basis of World Bank estimates of infant and mortality rates for 1990. For Scenario 3, the lowest sub-regional rates of infant and child mortality were similarly established on the basis of World Bank estimates.
Results
As the first step of the analysis, life expectancies were tabulated for the countries of Eastern Europe and Central Asia, using national registration data supplied to the WHO.
In the case of Central Asia and the Caucasus, this analysis was complemented by an adjustment of life tables with World Bank estimates on infant and child mortality.
Because these estimates show much higher values than the official data reported to the WHO, life expectancies in all countries of this region would be considerably lower if the World Bank's estimates of infant and child mortality rates are assumed to be more accurate. Figure 1 shows the results of recalculations of life tables according to different estimates of infant and child mortality. The difference is most dramatic for Tajikistan, where life expectancy would be reduced by 13.4 years.
Figure 1
Using the calculated life expectancies, the impact of the different scenarios on life expectancy was then analyzed. For the countries of Central Asia and the Caucasus, two complimentary analyses were undertaken, the first based on national registration data, the second based on World Bank estimates of infant and child mortality rates.
The results of the four scenarios are summarized in Table 1 and 2 and Figure 2 . In the whole of Eastern Europe and Central Asia, as well as in all four sub-regions and in most individual countries, the gain in life expectancy was by far greatest in Scenario 4.
Reducing mortality levels from cardiovascular disease and external causes of death to EU-15 levels would result in an average gain of 7.75 years.
The reductions in infant, child and maternal mortality in Scenarios 1-3, on the other hand, would result in markedly lower gains in life expectancy. Scenario 1 (reaching the MDGs for infant, child and maternal mortality) resulted in an average ECA gain of between 0.68 and 1.24 years. Scenario 2 (reaching EU-15 levels for infant, child and maternal mortality) would result in an average gain of 0.85-1.57 years, while Scenario 3 (reaching the lowest sub-regional levels of infant, child and maternal mortality) would result in an average gain of 0.58-1.09 years.
In Central Asia and the Caucasus, gains in the first three scenarios were considerably higher, when the calculations were based on World Bank estimates of infant and child mortality. In this case, average sub-regional gains would be 4.04 years in Scenario 1, 
Implications for systems of data collection
One of the major issues this study faced was the scale of the problems with existing data on which to judge progress towards identified targets in many countries. As noted above, there is currently no consensus on the true scale of infant and child mortality rates in Central Asia and the Caucasus. Estimates differ not only between national governments and international organizations, but between UN organizations themselves. This ultimately threatens the credibility of the estimates. International agencies should publish the basis on which they have derived their estimates for key health indicators and should initiate a process to achieve consensus on the best estimates for each country.
It is especially important to involve national governments in this dialogue, thus securing national ownership of estimates generated by international organizations and strengthening the case for improvements in national vital registration. It is essential that the governments of Central Asia and the Caucasus recognize that life expectancies are likely to be dramatically lower than official data suggest.
Governments and international agencies should place a high priority on strengthening systems for vital registration. As a first step it will be necessary to address the main factors that contribute to the discrepancies between official and survey data in Central Asia and the Caucasus. First, it is important that all countries adopt and implement fully the WHO definition of a live birth rather than the Soviet one. Second, training for health care staff is required to reduce misreporting of infant deaths. This will need to be accompanied by the abolition of incentives that lead staff to underreport infant mortality, such as the systems of control and sanctions that inhibit open discussion of adverse events. It will also require the creation of suitable incentives to increase the accuracy of reporting. Third, to ensure the reporting of births and deaths by parents, registration fees should be abolished where they still exist, as in Georgia. There are also many examples of how registration can be linked to access to benefits (financial and otherwise) to create positive incentives to improve vital registration. However it should also be recognized that some countries in Central Asia or the Caucasus may be reluctant to improve the accuracy of their data, as high official infant mortality rates would portray their countries in a negative light.
While national registration is still incomplete, it is possible to improve the quality of survey data. One way is by increasing the sample sizes, consequently narrowing confidence intervals and providing more accurate estimates, as well as by increasing the number of surveys, taking into account the problem of selective non-response of interviewees. This is most acute in the countries of Central Asia and the Caucasus, but also concerns other countries in Eastern Europe and Central Asia, where concerns about the quality of data have been raised, but where hardly any surveys have been undertaken so far.
Policy choices and combination of indicators
Obviously, health targets and policy interventions need to be adapted to the individual country context. Perhaps the most important message of this study is that simply following global development targets will not be the best way to enhance the health of the populations in Eastern Europe and Central Asia. The reason for this is that the burden of disease and mortality varies widely between countries and generally differs markedly from the patterns observed in developing countries.
The eight countries of Central Asia and the Caucasus exhibit very high under-5 and maternal mortality rates. It is those countries that would benefit most from achieving the MDGs as this will lead to a substantial improvement in overall health. In those countries where infant, under-5 and maternal mortality remain high there is a continuing need to direct resources to policies that will reduce them. This is likely to include strengthening basic social services and primary health care although, given the need to reflect local context, it will also be important not simply to transfer uncritically policies from other parts of the world. Instead, international agencies, bilateral donors and global foundations should support primary research into the causes of adverse health outcomes among these populations.
In addition to high rates of childhood mortality, some of the countries of Central Asia and the Caucasus are at the same time struggling with staggering rates of adult mortality.
One of the main findings that emerged from this study is that the health-related MDGs need to be adapted to Eastern Europe and Central Asia, so that they include adult mortality. This is particularly true of the countries of the former Soviet Union, but also of other countries of Eastern Europe and Central Asia. A potential average gain of 7.75 years in life expectancy at birth, when reducing mortality from cardiovascular diseases and external causes of death to EU-15 levels, simply cannot be ignored.
There are various ways in which adult mortality could be included in the MDGs. One way of doing so would be to include additional health indicators under Target 8 of Goal 6. At the most general level, life expectancy at birth could be used as an additional indicator. More specifically, major causes of adult mortality could be used as indicators of development. Although there are problems with the accuracy of mortality data in some countries of the region, these inaccuracies are unlikely to be any greater than those for traditional MDG indicators, and may even be less. Two additional indicators important for Eastern Europe and Central Asia are those used in this study, namely mortality rates from cardiovascular disease and external causes of death.
Need for development assistance
It is not necessary to wait for mortality levels to change to assess progress. Instead, it is possible to intervene to address the main risk factors for cardiovascular disease, tracking changes that will appear before mortality declines. Cardiovascular disease arises as a consequence of a complex set of risk factors, including tobacco use, physical inactivity and unhealthy diet and although the precise contribution of different factors in this region differs from that in western populations (for example, the very low levels of dietary antioxidants and the consequences of episodic heavy drinking), changes in the prevalence of key risk factors could be used as additional indicators under Target 8 of Millennium Development Goal 6. So far, however, available data on the prevalence of relevant risk factors is very limited. Again, the gathering of more accurate data would help to direct policy responses to where they are most needed.
Appropriate policy interventions to reduce the high levels of adult mortality must include the strengthening of public health services, with more emphasis on health promotion and disease prevention. Concerted public health efforts are in particular required to counteract the tobacco epidemic which is spreading in Eastern Europe and Central Asia.
The spread of tuberculosis, including multidrug-resistant tuberculosis, and HIV/AIDS are other strong reminders of the need for such improvements in public health programs, including health promotion activities. The high rates of external causes of death, in particular among infants and children, call for concerted efforts to prevent injuries, especially during childhood.
In general, international assistance should be focused on the countries in Eastern Europe and Central Asia with the largest burden of disease and premature mortality. As this study has shown, this concerns not only infant, child and maternal mortality, but also adult mortality. In this sense, the current study highlights where the need for development assistance in the health sector is greatest. The allocation of resources to the countries with the highest burden of mortality and disease could also be an incentive to improve vital registration systems.
Conclusion
A policy aimed at reducing mortality levels from cardiovascular disease and external causes of death to the levels in the EU-15 emerges as having the greatest potential to impact on life expectancy at birth, outweighing potential gains that might be achieved when reducing infant and child mortality. In summary, it can therefore be concluded that this study has made the case for complementing the MDGs in Eastern Europe and Central Asia with another set of goals or indicators that take into account adult mortality, while at the same time showing the benefits of reducing infant and child mortality in Central Asia and the Caucasus. In order to judge progress towards identified targets, governments and international agencies need to place a high priority on strengthening systems for vital registration, in particular in the countries of Central Asia and the Caucasus.
As already noted, Millennium Development Goal 6 could be used to complement the traditional MDGs, focusing on reversing the spread of HIV/AIDS and reducing the incidence of malaria and "other major diseases". Yet, the only other disease specified in the related indicators in addition to HIV/AIDS and malaria is tuberculosis. Nevertheless, the use of the term "other major diseases" in the Goal makes it possible to include other major diseases that are more relevant in a specific country or regional context. This might leave countries room within the framework of the MDGs to identify and tackle the diseases that cause the most damage to their populations, offering an opportunity for dialogue between governments and international agencies to operationalize appropriate targets. In Eastern Europe and Central Asia, these targets should include cardiovascular diseases and external causes of death, including the prevention of accidents, suicides and homicides. Both cardiovascular diseases and external causes of death are much more prevalent among males than among females and policies addressing their causes need to take account of this gender dimension. This study highlights the great variety among the countries of Eastern Europe and Central Asia. As the potential gains in life expectancy indicate, levels of infant, child and maternal mortality, as well as of mortality from cardiovascular diseases and external causes, vary widely among the different countries of the region. At one extreme is Slovenia, which would achieve almost no gain in life expectancy in the first three 
